PCVX Operating Cash Flow (Statement)
Vaxcyte Inc · Operating Cash Flow (Statement)
PCVX Operating Cash Flow (Statement)
Latest reported-$1.16Bperiod ending
PCVX TTM Cash from Operations (-$47.15M → -$1.16B)
TTM operating cash flow (statement)
High-resolution chart · PNG
PCVX operating cash flow (statement) history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Operating Cash Flow (Statement) (USD) |
|---|---|
| -1,161,858,000 | |
| -769,928,000 | |
| -655,577,000 | |
| -542,146,000 | |
| -459,549,000 | |
| -459,777,000 | |
| -452,627,000 | |
| -470,036,000 | |
| -466,876,000 | |
| -408,224,000 | |
| -296,790,000 | |
| -233,201,000 | |
| -214,201,000 | |
| -190,585,000 | |
| -170,597,000 | |
| -156,469,000 | |
| -146,336,000 | |
| -135,890,000 | |
| -121,393,000 | |
| -81,068,000 | |
| -65,708,000 | |
| -46,200,000 | |
| -46,628,000 | |
| -50,266,000 | |
| -46,669,000 | |
| -51,010,000 | |
| -47,145,000 |